Pentosan Polysulfate Sodium [PPS] (Elmiron®)

Assessment Status Rapid Review Complete
Drug Pentosan Polysulfate Sodium [PPS]
Brand Elmiron®
Indication For the treatment of bladder pain syndrome (BPS) characterized by either glomerulations or Hunner’s lesions in adults with moderate to severe pain, urgency and frequency of micturition.
Assessment Process
Rapid review commissioned 07/12/2018
Rapid review completed 24/01/2019
Rapid review outcome A full HTA is not recommended. The NCPE recommends that PPS not be considered for reimbursement at the submitted price. 

This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013.